Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
AIDS Research and Human Retroviruses|September 20, 2021
An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine/Tenofovir Disoproxil FumarateIan M McGowan, Ratiya Pamela Kunjara Na Ayudhya, Rhonda M Brand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 24, 2019
Short- and Long-Term Pharmacologic Measures of HIV Pre-exposure Prophylaxis Use Among High-Risk Men Who Have Sex With Men in HPTN 067/ADAPTJennifer Velloza, Peter Bacchetti, Craig W Hendrix, et al.
The Journal of Infectious Diseases|May 3, 2019
Standard-Dose Intradermal Influenza Vaccine Elicits Cellular Immune Responses Similar to Those of Intramuscular Vaccine in Men With and Those Without HIV InfectionSamuel Amoah, Margarita Mishina, Prabda Praphasiri, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2013
Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anusM J McElrath, K Smythe, J Randolph-Habecker, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serumTimothy A Bates, Hans C Leier, Zoe L Lyski, et al.
Nature Communications|August 27, 2021
Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serumTimothy A Bates, Hans C Leier, Zoe L Lyski, et al.
Plos One|February 25, 2015
Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypesYen T Duong, Reshma Kassanjee, Alex Welte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2018
Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT StudyRobert M Grant, Sharon Mannheimer, James P Hughes, et al.
Cell Reports. Medicine|October 5, 2020
Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV InfectionSean M Hughes, Claire N Levy, Fernanda L Calienes, et al.
Vaccine|November 16, 2023
Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023Ian D Plumb, Melissa Briggs Hagen, Ryan Wiegand, et al.
Pageof 7